What type of prostate cancer is Erleada used to treat?

Erleada (apalutamide) from Janssen is used for the treatment of prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). Erleada blocks androgens such as testosterone, a hormone that can promote tumor growth. The approval of Erleada is the first to use the endpoint of “metastasis-free survival”, measuring the length of time after starting treatment that tumors did not spread in the body or that death occurred.